Geron

After 33 years, Geron’s first approval marks a turn in Nobel-winning science
Pharma Voice
Wed, 06/26/24 - 09:57 am
Geron
Rytelo
imetelstat
FDA
Nobel Prize
Geron surges after winning first US FDA approval for blood disorder drug
Reuters
Fri, 06/7/24 - 11:14 am
Geron
Rytelo
FDA
myelodysplastic syndromes
Geron's blood disorder drug gets FDA advisers' backing
Reuters
Thu, 03/14/24 - 06:26 pm
Geron
FDA
imetelstat
Geron faces uphill battle at FDA meeting as agency questions benefit-risk profile of imetelstat
Fierce Biotech
Wed, 03/13/24 - 10:37 am
Geron
FDA
imetelstat
blood cancers
FDA staff raises concerns on Geron's blood disorder drug
Reuters
Tue, 03/12/24 - 11:06 am
Geron
FDA
imetelstat
myelodysplastic syndrome
After 33 years Geron could have an approved drug
EP Vantage
Wed, 01/4/23 - 09:44 am
Geron
imetelstat
clinical trials
myelodysplastic syndromes
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Did Geron's Big Announcement Just Go Unnoticed?
Yahoo/Motley Fool
Thu, 05/16/19 - 06:50 pm
Geron
imetelstat
myelofibrosis
3 Cancer Treatment Stocks on a Growth Trend
Motley Fool
Sun, 04/21/19 - 10:33 pm
Geron
AbbVie
Exelixis
cancer
[video+transcript]How Geron's Horrible Year Is a Great Reminder to Investors
Motley Fool
Sun, 11/4/18 - 02:36 pm
Geron
JNJ
imetelstat
Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?
Motley Fool
Sat, 09/29/18 - 12:04 am
Geron
JNJ
J&J has decided — pharma giant dumps its development deal on Geron’s imetelstat, shattering shares
Endpoints
Thu, 09/27/18 - 10:02 am
JNJ
Geron
imetelstat
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Mon, 09/3/18 - 12:20 pm
Amarin
CRISPR Therapeutics
Geron
Vascepa
Vertex Pharmaceuticals
CTX001
JNJ
imetelstat
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
Yahoo/Motley Fool
Tue, 08/28/18 - 10:07 am
JNJ
Geron
hirings
imetelstat
Imbruvica
2 Biotech Stocks Poised for Jaw-Dropping Growth
Motley Fool
Sun, 07/22/18 - 12:34 pm
Geron
Viking Therapeutics
imetelstat
VK5211
A Huge Decision Is on Tap for This Little Biotech Stock
Yahoo/Motley Fool
Wed, 05/16/18 - 09:20 am
Geron
JNJ
imetelstat
myelofibrosis
3 Biotech Stocks That Skyrocketed This Week
Motley Fool
Sun, 03/25/18 - 11:29 am
biotech
Geron
imetelstat
Arena Pharmaceuticals
etrasimod
Heron Therapeutics
HTX-011
5 Biotech Buyout Candidates for 2018
Yahoo/Motley Fool
Wed, 12/13/17 - 09:36 am
biotech
M&A
Biogen
Biomarin
Bluebird Bio
Geron
SAGE Therapeutics

Pages